X-16829598-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000380122.10(TXLNG):c.692G>A(p.Arg231Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,209,264 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000027 ( 0 hom. 0 hem. )
Consequence
TXLNG
ENST00000380122.10 missense
ENST00000380122.10 missense
Scores
3
6
8
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
TXLNG (HGNC:18578): (taxilin gamma) This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXLNG | NM_018360.3 | c.692G>A | p.Arg231Gln | missense_variant | 5/10 | ENST00000380122.10 | NP_060830.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXLNG | ENST00000380122.10 | c.692G>A | p.Arg231Gln | missense_variant | 5/10 | 1 | NM_018360.3 | ENSP00000369465.5 | ||
TXLNG | ENST00000398155.4 | c.296G>A | p.Arg99Gln | missense_variant | 3/8 | 1 | ENSP00000381222.4 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111632Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33814
GnomAD3 genomes
AF:
AC:
1
AN:
111632
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33814
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182587Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67107
GnomAD3 exomes
AF:
AC:
1
AN:
182587
Hom.:
AF XY:
AC XY:
0
AN XY:
67107
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1097632Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 363012
GnomAD4 exome
AF:
AC:
3
AN:
1097632
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
363012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111632Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33814
GnomAD4 genome
AF:
AC:
1
AN:
111632
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33814
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2024 | The c.692G>A (p.R231Q) alteration is located in exon 5 (coding exon 5) of the TXLNG gene. This alteration results from a G to A substitution at nucleotide position 692, causing the arginine (R) at amino acid position 231 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Uncertain
D;D
Polyphen
P;D
Vest4
MutPred
Loss of MoRF binding (P = 0.1517);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at